Traumatic Hemothorax Drainage and Daily Lavage

Part of paid clinical trials in Philadelphia, Pennsylvania.

Sponsor
University of Pennsylvania
Study ID
NCT06937450
Status
Recruiting
Apply to this trial

Conditions

  • Hemothorax; Traumatic

Eligibility Criteria

Sex
ALL
Age
15 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • CLR Irrigator — DEVICE
    All enrolled patients will have their hemothorax treated with a CLR device that allows for easy suction and irrigation through indwelling catheters,
  • Serial Lavage and Drainage — PROCEDURE
    The current protocol is to do a singular lavage and drainage, this study will investigate the benefits of daily lavage.
  • 28 Fr Open Chest Tube — DEVICE
    Patients will have a standard 28 Fr open chest tube or a percutaneous 14Fr chest tube placed.
  • Percutaneous 14Fr Chest Tube — DEVICE
    Patients will have a standard 28 Fr open chest tube, or a percutaneous 14Fr chest tube placed.

Study Details

This HTX treatment study evaluates the effects of chest tube size and the benefits of daily irrigations on acute HTX. 20 acutely injured but stable trauma patients requiring a chest tube for HTX will be enrolled. Patients will be assigned a 28Fr or 14 Fr chest tube with serial lavage and drainage. The endpoints will be HTX volume (by CT scan), complications, additional interventions, hospital length of stay, chest tube duration, provider feedback, and patient-reported outcomes.

Key Dates

Start date
Mar 3, 2025
Status verified
Apr 2026
Primary completion
Aug 1, 2026
Completion
Aug 1, 2027

Study Design

Enrollment
20 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Open 28 Fr Tube Thoracostomy with Daily Lavage and Drainage
    Open Tube Thoracostomy with Daily Lavage and Drainage
  • Experimental: Percutaneous 14-Fr Catheter with Daily Lavage and Drainage
    Percutaneous 14-Fr Catheter with Daily Lavage and Drainage

Primary Outcome Measure

Remaining Hemothorax Volume at 72 hours [ Time Frame: 72 hours ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Penn Presbyterian Medical CenterPhiladelphiaPennsylvania19104-

Find similar trials in Philadelphia, PA

By research site
Penn Presbyterian Medical Center· Philadelphia, PA

Related Studies